JOIN US

REFLEXION LUNCHEON AT AAPM

July 20, 2026 at 12:30 PM PDT | East Ballroom B, Vancouver Convention Center

RSVP

Join us on July 20th at 12:30PM PDT for an in-depth look at emerging scientific data from X2, our next-generation platform. Key opinion leaders will present their findings, followed by an interactive panel discussion. This session offers an opportunity to hear firsthand perspectives on the new foundation for SCINTIX® therapy.

SCINTIX THERAPY

SCINTIX® technology is a novel therapy for patients with tumors in the lung or bone arising from primary and metastatic cancer. This breakthrough technology uses live, continuously updated data throughout the entire treatment session to determine where to deliver radiotherapy.

The X2 platform is FDA-cleared for primary and metastatic lung and bone tumors. The new Anchor Point™ Tracking algorithm is under development and is not yet available for sale.

LEARN MORE

DISCLOSURES

As a health care professional attendee of this event, you understand and agree that for purposes of complying with RefleXion’s mandatory transparency reporting obligations under the Patient Protection and Affordable Care Act (together with any regulations and official guidelines promulgated thereunder) and any applicable state reporting requirements, RefleXion may collect, aggregate and report any and all payments made pursuant to this event.